AlphaQuest’s Jade Biosciences JBIO Stock Holding History

AlphaQuest’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-939	Closed	-$54.5K	–	1881
2024 Q2	$54.5K	Buy	939 +807	+611%	+$535K	0.01%	1059
2024 Q1	$137K	Buy	+132	New	+$101K	0.02%	752

Other funds holding JBIO

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

AlphaQuest's JBIO Position: Q3 2024 in Review

AlphaQuest sold out of Jade Biosciences (JBIO) in Q3 2024, closing a stake of 939 shares — an estimated $54.5K sold.

AlphaQuest first reported a position in JBIO in Q1 2024 and held it in 2 quarters. The position peaked at $137K in Q1 2024. 72 funds tracked by Wall St. Rank hold JBIO as of Q3 2024.

AlphaQuest reported no remaining Jade Biosciences position as of Q3 2024 after selling out during the quarter.
AlphaQuest sold 939 Jade Biosciences shares in Q3 2024, an estimated $54.5K.
AlphaQuest first reported a position in Jade Biosciences in Q1 2024 and held it in 2 quarters.
AlphaQuest's Jade Biosciences position peaked at $137K in Q1 2024.
72 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2024.

Based on AlphaQuest's 13F filing for Q3 2024, filed 7 Nov 2024.